Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microalgae Ask Us (MAUS) is a South Korean biotechnology company specializing in the development, cultivation, and standardization of natural bio-materials derived from microalgae. Established in October 2020 as a spin-off from the Korea Institute of Science and Technology (KIST), the company utilizes an advanced, land-based indoor tank-type smart-farming system and an AI-driven microalgae biological dataset library to produce high-value functional ingredients. Its flagship product, Tisochrysis lutea powder, is officially recognized by South Korea's Ministry of Food and Drug Safety (MFDS) as an individual health functional food ingredient for improving dry eye syndrome. Additionally, the company commercializes vegan cosmetics under its 'healara' brand, featuring fucoxanthin and microalgal extracts, and is expanding its pipeline into metabolic health, anti-obesity, and osteoarthritis treatments. MAUS operates as a subsidiary of Daesang Holdings, which acquired a majority stake in the company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microalgae Ask Us.